Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Northwest Compounding Pharmacy is recalling 60 ml bottles of Glutathione liquid, 100mg/ml, due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Hydroxyprogesterone liquid, 250mg/ml, due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Lidocaine/Epinephrine liquid 1%/1:1000 in 50 ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Methocarbamol liquid 100mg/ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling compounded Cyclosporin liquid 0.2% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling specific lots of compounded Cyclosporin liquid 2% for dry eye due to a lack of sterility assurance. The product was distributed in Oregon.
Northwest Compounding Pharmacy is recalling MIC B vitamin liquid due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling compounded Cyclosporin liquid 0.5% in plastic dropper bottles due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities, a physician's office, and patients.
Northwest Compounding Pharmacy is recalling compounded cyclosporin liquid 1% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Vitamin B12 liquid 1000mcg/ml due to lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Epinephrine liquid 1:1000 in 50 ml glass vials due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Lidocaine gel 2% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Testosteron Cypionate liquid 200mg/ml because of a lack of sterility assurance. The product was distributed in Oregon to medical facilities, a physician's office, and patients.
Northwest Compounding Pharmacy is recalling Lidocaine gel 1% in Oregon due to a lack of sterility assurance. The product was distributed to medical facilities and patients.
Northwest Compounding Pharmacy is recalling Cyclosporin liquid 0.05% due to a lack of sterility assurance. The product was distributed in Oregon to medical facilities and patients.
Lupin Pharmaceuticals is recalling specific lots of Nitrofurantoin Oral Suspension because the drug was found to contain less active ingredient than required.
Advanced Pharma Inc. is recalling 225 syringes of Phenylephrine HCl injectable solution because the label incorrectly states the concentration as 10 mcg per mL instead of 100 mcg per mL.
Amerigen Pharmaceuticals is recalling specific lots of Temozolomide Capsules because they failed to meet dissolution specifications.
Amerigen Pharmaceuticals is recalling Temozolomide Capsules, 180 mg, due to failed dissolution specifications. The FDA classified this as a Class III recall.
Results RNA, LLC is recalling Lubrisine eye drops nationwide due to lack of sterility assurance and the presence of undeclared colloidal silver.
Pharm D Solutions is recalling 85 vials of Human Chorionic Gonadotropin 3000 IU due to inadequate processes to assure sterility.
Enovachem is recalling Dyural-80 Injection Kits because the product insert incorrectly stated that the stoppers do not contain latex, when they actually contain natural rubber latex.
Pfizer is voluntarily recalling 1,996 bottles of Levoxyl 112 mcg tablets nationwide because the drug is superpotent.
Asclemed USA Inc. is recalling Dyural-40 Injection Kits because the product insert incorrectly states that the stoppers do not contain latex, when they actually do.
Pharmedium Services, LLC is voluntarily recalling 295 bags of Fentanyl Citrate and Ropivacaine HCl injection because the product was found to be sub-potent.